logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Anthony Donofrio

This inventor holds 15 USPTO granted patents and 1 published patent application and 11 EPO patents, primarily in Kinase Inhibitors. Top assignees: Merck Sharp + Dohme Corp., Merck Canada Inc., Merck Sharp & Dohme LLC. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony Donofrio. Retrieved from https://idiyas.com/inventor/anthony-donofrio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 80.0

 

Average Co-Inventor Count = 14.9

ph-index = 5

Forward Citations = 73(Granted Patents)


Company Filing History:

goldMedal12 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal6 out of 40 
 
Merck Canada Inc.
 patents
bronzeMedal3 out of 73 
 
Merck Sharp & Dohme LLC
 patents
where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
HPK1 Inhibitors
SYK Inhibitors
IRAK4 Inhibitors
Aminopyrimidines
Thiazole-Substituted Compounds
Phenyl Substituted Compounds
Triazolyl Derivatives
Pyridine Compounds
Bipyridylaminopyridines
2-Aminoquinazoline
Carboxamide Inhibitors
Spleen Tyrosine Kinase
15 patents (USPTO):Explore Patents
1. 12753163 - Diaminopyrimidine carboxamide inhibitors of HPK1 (2026-10-06),
2. 12735431 - 7-phenyl substituted 2-aminoquinazoline inhibitors of HPK1 (2026-09-15),
3. 12492187 - Factor XI activation inhibitors (2025-12-09),
4. 9969749 - Inhibitors of IRAK4 activity (2018-05-15),
5. 9943516 - Inhibitors of IRAK4 activity (2018-04-17),
6. 9932350 - Inhibitors of IRAK4 activity (2018-04-03),
7. 9926330 - Inhibitors of IRAK4 activity (2018-03-27),
8. 9745295 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors (2017-08-29),
9. 9586931 - Triazolyl derivatives as Syk inhibitors (2017-03-07),
10. 9487504 - Imidazolyl analogs as syk inhibitors (2016-11-08),
11. 9376418 - Substituted pyridine spleen tyrosine kinase (SYK) inhibitors (2016-06-28),
12. 9216173 - 2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors (2015-12-22),
13. 9145391 - Bipyridylaminopyridines as Syk inhibitors (2015-09-29),
14. 8987456 - 3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors (2015-03-24),
15. 8551984 - Aminopyrimidines as SYK inhibitors (2013-10-08),

Title: The Innovative Mind of Anthony Donofrio

Introduction: Anthony Donofrio, a talented inventor based in Cambridge, MA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Anthony Donofrio holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Anthony Donofrio has worked with top tech companies, leading research institutions, and universities, where he has spearheaded projects that have revolutionized the industry.

Collaborations: Throughout his career, Anthony Donofrio has collaborated with renowned scientists, engineers, and researchers, fostering a culture of innovation and creativity in every project he undertakes.

Conclusion: Anthony Donofrio's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…